M&A / Deals Deep Science Ventures and MDC partner to accelerate brain treatments PharmaTimesNew collaboration aims to break barriers in braintargeted drug discoveryNeuroscienceRead full story pharminent June 2, 2026 (Last updated: June 4, 2026) PharmaTimes New collaboration aims to break barriers in braintargeted drug discovery Neuroscience Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: BMS secures FDA acceptance for Camzyos sNDANext: Abivax slides on phase 3 data in ulcerative colitis Related Stories M&A / Deals Supernus and Indivior merge to create CNS mega-company with 11 approved drugs pharminent August 3, 2026 M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026
